These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 27696685)
21. Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein. Singh A; Batra JK Biol Chem; 2011 Apr; 392(4):337-46. PubMed ID: 21303303 [TBL] [Abstract][Full Text] [Related]
22. Role of β-naphthylalanine end-tags in the enhancement of antiendotoxin activities: Solution structure of the antimicrobial peptide S1-Nal-Nal in complex with lipopolysaccharide. Yu HY; Chen YA; Yip BS; Wang SY; Wei HJ; Chih YH; Chen KH; Cheng JW Biochim Biophys Acta Biomembr; 2017 Jun; 1859(6):1114-1123. PubMed ID: 28288781 [TBL] [Abstract][Full Text] [Related]
23. Mechanisms of endotoxin neutralization by synthetic cationic compounds. Andrä J; Gutsmann T; Garidel P; Brandenburg K J Endotoxin Res; 2006; 12(5):261-77. PubMed ID: 17059690 [TBL] [Abstract][Full Text] [Related]
24. Biophysical analysis of the interaction of granulysin-derived peptides with enterobacterial endotoxins. Chen X; Howe J; Andrä J; Rössle M; Richter W; da Silva AP; Krensky AM; Clayberger C; Brandenburg K Biochim Biophys Acta; 2007 Oct; 1768(10):2421-31. PubMed ID: 17555705 [TBL] [Abstract][Full Text] [Related]
25. The sulfate-binding site structure of the human eosinophil cationic protein as revealed by a new crystal form. Boix E; Pulido D; Moussaoui M; Nogués MV; Russi S J Struct Biol; 2012 Jul; 179(1):1-9. PubMed ID: 22579681 [TBL] [Abstract][Full Text] [Related]
26. [Advances in the development of neutralizing therapies for sepsis]. Florencia Henning M; Garda H; Bakás L Medicina (B Aires); 2006; 66(3):263-73. PubMed ID: 16871917 [TBL] [Abstract][Full Text] [Related]
27. Development of small-molecule endotoxin sequestering agents. David SA; Sil D Subcell Biochem; 2010; 53():255-83. PubMed ID: 20593271 [TBL] [Abstract][Full Text] [Related]
28. Bound to shock: protection from lethal endotoxemic shock by a novel, nontoxic, alkylpolyamine lipopolysaccharide sequestrant. Sil D; Shrestha A; Kimbrell MR; Nguyen TB; Adisechan AK; Balakrishna R; Abbo BG; Malladi S; Miller KA; Short S; Cromer JR; Arora S; Datta A; David SA Antimicrob Agents Chemother; 2007 Aug; 51(8):2811-9. PubMed ID: 17548488 [TBL] [Abstract][Full Text] [Related]
29. Definition of endotoxin binding sites in horseshoe crab factor C recombinant sushi proteins and neutralization of endotoxin by sushi peptides. Tan NS; Ng ML; Yau YH; Chong PK; Ho B; Ding JL FASEB J; 2000 Sep; 14(12):1801-13. PubMed ID: 10973930 [TBL] [Abstract][Full Text] [Related]
30. Towards a rational development of anti-endotoxin agents: novel approaches to sequestration of bacterial endotoxins with small molecules. David SA J Mol Recognit; 2001; 14(6):370-87. PubMed ID: 11757070 [TBL] [Abstract][Full Text] [Related]
31. Lipopolysaccharide neutralization by the antibacterial peptide CM4. Lin QP; Zhou LF; Li NN; Chen YQ; Li BC; Cai YF; Zhang SQ Eur J Pharmacol; 2008 Oct; 596(1-3):160-5. PubMed ID: 18789317 [TBL] [Abstract][Full Text] [Related]
32. Characterization of molecular interactions between eosinophil cationic protein and heparin. Fan TC; Fang SL; Hwang CS; Hsu CY; Lu XA; Hung SC; Lin SC; Chang MD J Biol Chem; 2008 Sep; 283(37):25468-25474. PubMed ID: 18593710 [TBL] [Abstract][Full Text] [Related]
33. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. Rosenfeld Y; Papo N; Shai Y J Biol Chem; 2006 Jan; 281(3):1636-43. PubMed ID: 16293630 [TBL] [Abstract][Full Text] [Related]
34. Endotoxin neutralizing peptides. Jerala R; Porro M Curr Top Med Chem; 2004; 4(11):1173-84. PubMed ID: 15279607 [TBL] [Abstract][Full Text] [Related]